Identification of novel regulators of Zalcitabine-Induced neuropathic pain

dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS)
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
dc.contributor.authorMartínez Rodríguez, Antón Leandro
dc.contributor.authorBrea Floriani, José Manuel
dc.contributor.authorDomínguez Medina, Eduardo
dc.contributor.authorVarela Liste, María José
dc.contributor.authorCimadevila Fondevila, Marta
dc.contributor.authorAllegue Toscano, Catarina
dc.contributor.authorCruz Guerrero, Raquel
dc.contributor.authorMonroy, Xavier
dc.contributor.authorMerlos, Manuel
dc.contributor.authorBurgueño, Javier
dc.contributor.authorCarracedo Álvarez, Ángel
dc.contributor.authorLoza García, María Isabel
dc.date.accessioned2026-01-13T09:20:44Z
dc.date.available2026-01-13T09:20:44Z
dc.date.issued2021-06-29
dc.description.abstractNeuropathic pain is one of the foremost adverse effects that worsens quality of life for patients undergoing an antiretroviral treatment. Currently, there are no effective analgesics for relieving it; thus, there is an urgent need to develop novel treatments for neuropathic pain. Previously, we described and validated F11 cells as a model of DRG (dorsal root ganglia) neurons. In the current work, we employed F11 cells to identify regulators of antiretroviral-induced neuropathic pain combining functional and transcriptomic analysis. The antiretroviral zalcitabine (ddC) increased the excitability of differentiated F11 cells associated with calcium signaling without morphological changes in the neuronal phenotype, mimicking the observed increase of painful signaling in patients suffering from antiretroviral-induced neuropathic pain. Employing RNA sequencing, we observed that zalcitabine treatment upregulated genes related with oxidative stress and calcium homeostasis. The functional impact of the transcriptomic changes was explored, finding that the exposure to zalcitabine significantly increased intracellular oxidative stress and reduced store-operated calcium entry (SOCE). Because the functional and transcriptomic evidence points toward fundamental changes in calcium signaling and oxidative stress upon zalcitabine exposure, we identified that NAD(P)H quinone dehydrogenase and the sarcoplasmic/endoplasmic reticulum calcium ATPase 3 were involved in zalcitabine-induced hyperexcitability of F11 cells. Overexpression of those genes increases the calcium-elicited hyperexcitability response and reduces SOCE, as well as increases intracellular ROS levels. These data do not only mimic the effects of zalcitabine but also highlight the relevance of oxidative stress and of calcium-mediated signaling in antiretroviral-induced hyperexcitability of sensory neurons, shedding light on new therapeutic targets for antiviral-induced neuropathic pain
dc.description.peerreviewedSI
dc.description.sponsorshipThis work was supported by the Joint R&D Unit Esteve-USC (IN853A-2017/6), cofinanced by the Galician Innovation Agency and the Spanish Ministry of Economy and Competitiveness (MINECO) within the framework of the Spanish Strategy of Innovation in Galicia, and by the Phenopain project (RTC-2015-4207-1) of the RETOS-COLABORACIÓN program of the MINECO, cofinanced by the European Union through the European Regional Development Fund (ERDF). A.L.M. was in receipt of a predoctoral fellowship from the FPU program (Spanish Ministry of Education, Culture and Sports)
dc.identifier.citationAntón L. Martínez, José Brea, Eduardo Domínguez, María J. Varela, Marta Cimadevila, Catarina Allegue, Raquel Cruz, Xavier Monroy, Manuel Merlos, Javier Burgueño, Ángel Carracedo, and María I. Loza ACS Chemical Neuroscience 2021 12 (14), 2619-2628 DOI: 10.1021/acschemneuro.1c00129
dc.identifier.doi10.1021/acschemneuro.1c00129
dc.identifier.issn1948-7193
dc.identifier.urihttps://hdl.handle.net/10347/45062
dc.issue.number14
dc.journal.titleACS Chemical Neuroscience
dc.language.isoeng
dc.page.final2628
dc.page.initial2619
dc.publisherACS Publications
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTC-2015-4207-1/ES/Desarrollo de Modelos Fenotípicos In Vitro de Dolor y su Aplicación al Cribado de Compuestos de Alto Rendimiento (High-Throughput Screening)
dc.relation.publisherversionhttps://doi.org/10.1021/acschemneuro.1c00129
dc.rights© 2021 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY-NC-ND 4.0
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectNeuropathic pain
dc.subjectAntiretrovirals
dc.subjectHyperexcitability,
dc.subjectAlcium transients
dc.subjectTranscriptomic assays
dc.subjectAdverse effects
dc.titleIdentification of novel regulators of Zalcitabine-Induced neuropathic pain
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication
relation.isAuthorOfPublicationefe7f464-2f77-4a92-915f-fda4128451fa
relation.isAuthorOfPublication67b19be7-64a8-45c8-a6e4-ed48a4410ef8
relation.isAuthorOfPublication82cda0bc-af07-4524-9c5e-2761614a82c5
relation.isAuthorOfPublication7765cb9b-b630-44dc-9477-dd266a62bb3c
relation.isAuthorOfPublication.latestForDiscoveryefe7f464-2f77-4a92-915f-fda4128451fa

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021_ACSChNeur_Martinez_Identification.pdf
Size:
3.33 MB
Format:
Adobe Portable Document Format